Pascoal, T. A., Mathotaarachchi, S., Mohades, S., Benedet, A. L., Chung, C., Shin, M., . . . Rosa-Neto, P. (2017). Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease. Mol Psychiatry.
Chicago Stili AlıntıPascoal, T A., et al. "Amyloid-β and Hyperphosphorylated Tau Synergy Drives Metabolic Decline in Preclinical Alzheimer's Disease." Mol Psychiatry 2017.
MLA AlıntıPascoal, T A., et al. "Amyloid-β and Hyperphosphorylated Tau Synergy Drives Metabolic Decline in Preclinical Alzheimer's Disease." Mol Psychiatry 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..